BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5962578)

  • 1. [Apropos of the appearance of chloasma during treatment with synthetic progestational agents].
    Rivoire J
    Bull Soc Fr Dermatol Syphiligr; 1966; 73(3):353-4. PubMed ID: 5962578
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apropos of the appearance of chloasma during treatment with synthetic progestational agents].
    Rivoire J
    Lyon Med; 1967 Mar; 217(13):954-5. PubMed ID: 6042243
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chloasmic type of pigmentation of the face during treatments with estrogens and progestational hormones].
    Basset H
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(2):166-8. PubMed ID: 6061306
    [No Abstract]   [Full Text] [Related]  

  • 4. Mood and behavioural changes with progestational agents.
    Kane FJ; Daly RJ; Ewing JA; Keeler MH
    Br J Psychiatry; 1967 Mar; 113(496):265-8. PubMed ID: 6029624
    [No Abstract]   [Full Text] [Related]  

  • 5. Galactorrhea after contraceptive hormones.
    Gregg WI
    N Engl J Med; 1966 Jun; 274(25):1432. PubMed ID: 5949006
    [No Abstract]   [Full Text] [Related]  

  • 6. [Phlebitis and chloasma in patient taking oral contraceptives].
    Merklen FP; Cottenot F; Potier JC
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(6):801-3. PubMed ID: 5590531
    [No Abstract]   [Full Text] [Related]  

  • 7. Strokes in young women using oral contraceptives.
    Cole M
    Arch Intern Med; 1967 Nov; 120(5):551-5. PubMed ID: 6054589
    [No Abstract]   [Full Text] [Related]  

  • 8. Some apparently common problems in patients receiving contraceptive pills.
    Ball P
    Nebr State Med J; 1968 Sep; 53(9):428-32. PubMed ID: 4176717
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral contraceptives and exacerbation of lupus erythematosus.
    Chapel TA; Burns RE
    Am J Obstet Gynecol; 1971 Jun; 110(3):366-9. PubMed ID: 5088375
    [No Abstract]   [Full Text] [Related]  

  • 10. Budd-Chiari syndrome in women taking oral contraceptives.
    Hoyumpa AM; Schiff L; Helfman EL
    Am J Med; 1971 Jan; 50(1):137-40. PubMed ID: 5539574
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral contraceptives and cerebral arterial occlusion.
    Illis L; Kocen RS; McDonald WI; Mondkar VP
    Br Med J; 1965 Nov; 2(5471):1164-6. PubMed ID: 5833621
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood coagulation and oral ovulostatic steroids. (Case studies of 22 women treated for a long period, from 6 months to 3 years, with norethynodrel and mestranol)].
    Conti M; Neglia V; Arrotta U
    Minerva Ginecol; 1967 Nov; 19(22):1091-4. PubMed ID: 5606233
    [No Abstract]   [Full Text] [Related]  

  • 13. Impairment of diabetic control by norethynodrel with mestranol.
    Reder JA; Tulgan H
    N Y State J Med; 1967 Apr; 67(8):1073-4. PubMed ID: 5232498
    [No Abstract]   [Full Text] [Related]  

  • 14. Irregular menses, amenorrhea, and infertility following synthetic progestational agents.
    Whitelaw MJ; Nola VF; Kalman CF
    JAMA; 1966 Feb; 195(9):780-2. PubMed ID: 5951886
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chloasma during treatments with synthetic estroprogestagens].
    Thiers H; Villedieu P; Moulin G
    G Ital Dermatol Minerva Dermatol; 1966; 107(5):1335-8. PubMed ID: 6014651
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chloasma, a complication of treatments with synthetic progestational hormones (7 cases)].
    Thiers H; Villedieu P; Moulin G
    J Med Lyon; 1966 Dec; 47(111):1815-6 passim. PubMed ID: 5990283
    [No Abstract]   [Full Text] [Related]  

  • 17. Collaborative study of the analysis of mestranol in combination with norethindrone or norethynodrel.
    Brunner CA
    J Assoc Off Anal Chem; 1971 May; 54(3):590-2. PubMed ID: 5162917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Galactorrhea induced by oral contraceptives].
    Sas M; Kincses L; Resch B
    Orv Hetil; 1973 Nov; 114(47):2845-6. PubMed ID: 4796441
    [No Abstract]   [Full Text] [Related]  

  • 19. [First case of steroid jaundice caused by norethindrone and mestranol in Japan].
    Hayashi K; Okamura H; Nishikawa Y; Miura Y; Ashidaka Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1966 Dec; 18(12):1461-4. PubMed ID: 6009965
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thromboelastographic changes in patients treated with an anovulatory drug with estro-progestinic action].
    Schubert L; Acerboni F; Gibelli A; Giarola P
    Minerva Ginecol; 1969 Oct; 21(19):1323-8. PubMed ID: 5407219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.